OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

P2X7R antagonists in chronic stress-based depression models: a review
Iven-Alex von Muecke-Heim, Clemens Ries, Lidia Urbina-Treviño, et al.
European Archives of Psychiatry and Clinical Neuroscience (2021) Vol. 271, Iss. 7, pp. 1343-1358
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

The NLRP3 inflammasome in depression: Potential mechanisms and therapies
Cong‐Yuan Xia, Yuxuan Guo, Wenwen Lian, et al.
Pharmacological Research (2022) Vol. 187, pp. 106625-106625
Open Access | Times Cited: 77

Present and future of microglial pharmacology
Eva Šimončičová, Elisa Gonçalves de Andrade, Haley A. Vecchiarelli, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 8, pp. 669-685
Open Access | Times Cited: 61

Astrocytes and major depression: The purinergic avenue
Yafei Zhao, Alexei Verkhratsky, Yong Tang, et al.
Neuropharmacology (2022) Vol. 220, pp. 109252-109252
Closed Access | Times Cited: 45

Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases
Huiyong Zheng, Qiang Liu, Siwei Zhou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10

High, in Contrast to Low Levels of Acute Stress Induce Depressive-like Behavior by Involving Astrocytic, in Addition to Microglial P2X7 Receptors in the Rodent Hippocampus
Yafei Zhao, Wenjing Ren, Ying Zhang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1904-1904
Open Access | Times Cited: 26

Allostatic load and systemic comorbidities in psychiatric disorders
Sabine Finlay, Donna Rudd, Brett McDermott, et al.
Psychoneuroendocrinology (2022) Vol. 140, pp. 105726-105726
Closed Access | Times Cited: 24

NLRP3-Dependent Pyroptosis: A Candidate Therapeutic Target for Depression
Teng Wan, Xiaoyü Li, Mingyuan Fu, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 22

Establishment and behavioural characterization of a novel constitutive P2X7 receptor knockout mouse line
Iven-Alex von Mücke-Heim, Judit Oldekamp, Michael Metzger, et al.
Purinergic Signalling (2025)
Open Access

The impact of the P2X7 receptor on the tumor immune microenvironment and its effects on tumor progression
Yu-ting Zou, Jinyuan Li, Jun-yi Chai, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 707, pp. 149513-149513
Closed Access | Times Cited: 4

Microglial NLRP3 inflammasome-mediated neuroinflammation and therapeutic strategies in depression
Qiu-Qin Han, Wenhui Li, Peiqing Chen, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 9, pp. 1890-1898
Open Access | Times Cited: 10

The human P2X7 receptor alters microglial morphology and cytokine secretion following immunomodulation
Iven-Alex von Mücke-Heim, Jana N. Martin, Manfred Uhr, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9

P2X7 receptor-mediated depression-like reactions arising in the mouse medial prefrontal cortex
Wenjing Ren, Yafei Zhao, Jie Li, et al.
Cerebral Cortex (2023) Vol. 33, Iss. 14, pp. 8858-8875
Closed Access | Times Cited: 9

NLRP3 inflammatory pathway. Can we unlock depression?
Ghazaleh Ghaffaripour Jahromi, Sepideh Razi, Nima Rezaei
Brain Research (2023) Vol. 1822, pp. 148644-148644
Closed Access | Times Cited: 8

P2X7 receptor: a potential target for treating comorbid anxiety and depression
Jun Liu, Tingting Liu, Lan Mou, et al.
Purinergic Signalling (2024)
Open Access | Times Cited: 2

P2X7Rs: new therapeutic targets for osteoporosis
Haoyun Huang, HE Yu-mei, Miaomiao Lin, et al.
Purinergic Signalling (2022) Vol. 19, Iss. 1, pp. 207-219
Open Access | Times Cited: 12

The P2X7 receptor in mood disorders: Emerging target in immunopsychiatry, from bench to bedside
Iven-Alex von Mücke-Heim, Jan M. Deussing
Neuropharmacology (2022) Vol. 224, pp. 109366-109366
Closed Access | Times Cited: 11

Variation along P2RX7 interacts with early traumas on severity of anxiety suggesting a role for neuroinflammation
Zsüliet Kristóf, Zsófia Gál, Dóra Török, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6

P2X7 Receptor-Related Genetic Mouse Models – Tools for Translational Research in Psychiatry
Lidia Urbina-Treviño, Iven-Alex von Mücke-Heim, Jan M. Deussing
Frontiers in Neural Circuits (2022) Vol. 16
Open Access | Times Cited: 10

P2X7 receptors: a bibliometric review from 2002 to 2023
Haiting Tang, Wei Wei, Yu Luo, et al.
Purinergic Signalling (2024)
Closed Access | Times Cited: 1

NEDD4 Like E3 Ubiquitin Protein Ligase Represses Astrocyte Activation and Aggravates Neuroinflammation in Mice with Depression via Paired Box 6 Ubiquitination
Xin Wang, Mingming Su, Lesheng Wang, et al.
Neuroscience (2023) Vol. 530, pp. 144-157
Closed Access | Times Cited: 4

Embers of the Past: Early Childhood Traumas Interact with Variation in P2RX7 Gene Implicated in Neuroinflammation on Markers of Current Suicide Risk
Zsüliet Kristóf, Zsófia Gál, Dóra Török, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 865-865
Open Access | Times Cited: 1

Involvement of inflammatory responses in the brain to the onset of major depressive disorder due to stress exposure
Shingo Miyata, Yugo Ishino, Shoko Shimizu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 5

Microglia Involves in the Immune Inflammatory Response of Poststroke Depression: A Review of Evidence
Weili Xia, Yong Zhi Xu, Yuandong Gong, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 4

Major depressive disorder (mdd): emerging immune targets at preclinical level
Manasi Varma, Arshpreet Kaur, Ranjana Bhandari, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 6, pp. 479-501
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top